Comprehensive analysis of transcript start sites in Ly49 genes reveals an unexpected relationship with gene function and a lack of upstream promoters

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Gays, Frances ^a   Koh, Alan S C ^a   Mickiewicz, Katarzyna M ^a   Aust, Jonathan G ^a   Brooks, Colin G ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; INTERLEUKIN 2; LUCIFERASE; LYSINE; MESSENGER RNA; OLIGONUCLEOTIDE; PYRIMIDINE; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY A;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL ACTIVATION; CONTROLLED STUDY; DENDRITIC CELL; EXON; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC ANALYSIS; GENETIC CODE; IN VITRO STUDY; INTRON; LYMPHOID CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; RECEPTOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA CAPPING; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; STOP CODON; STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE ACTIVATION; TISSUE SPECIFICITY; TRANSCRIPTION INITIATION SITE; ANIMAL; CELL CULTURE; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS;

MUS;

ANIMALS; CELLS, CULTURED; EXONS; FLUORESCENT ANTIBODY TECHNIQUE; MICE; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY A; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION SITE;

EID: 79953662882     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018475     Document Type: Article

References (49)

1. Yokoyama WM, Plougastel BF, (2003) Immune functions encoded by the natural killer gene complex. Nat Rev Immunol 3: 304-316.
2. Dimasi N, Biassoni R, (2005) Structural and functional aspects of the Ly49 natural killer cell receptors. Immunol Cell Biol 83: 1-8.
3. Raulet DH, Held W, Correa I, Dorfman JR, Wu MF, et al. (1997) Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunol Rev 155: 41-52.
4. Held W, Kunz B, (1998) An allele-specific, stochastic gene expression process controls the expression of multiple Ly49 family genes and generates a diverse, MHC-specific NK cell receptor repertoire. Eur J Immunol 28: 2407-2416.
5. Takei F, McQueen KL, Maeda M, Wilhelm BT, Lohwasser S, et al. (2001) Ly49 and CD94/NKG2: developmentally regulated expression and evolution. Immunol Rev 181: 90-103.
6. Coles MC, McMahon CW, Takizawa H, Raulet DH, (2000) Memory CD8 T lymphocytes express inhibitory MHC-specific Ly49 receptors. Eur J Immunol 30: 236-244.
7. Toomey JA, Shrestha S, de la Rue SA, Gays F, Robinson JH, et al. (1998) MHC class I expression protects target cells from lysis by Ly49-deficient fetal NK cells. Eur J Immunol 28: 47-56.
8. Van Beneden K, De Creus A, Stevenaert F, Debacker V, Plum J, et al. (2002) Expression of inhibitory receptors Ly49E and CD94/NKG2 on fetal thymic and adult epidermal TCR V gamma 3 lymphocytes. J Immunol 168: 3295-3302.
9. Gays F, Martin K, Kenefeck R, Aust JG, Brooks CG, (2005) Multiple cytokines regulate the NK gene complex-encoded receptor repertoire of mature NK cells and T cells. J Immunol 175: 2938-2947.
10. Fraser KP, Gays F, Robinson JH, van Beneden K, Leclercq G, et al. (2002) NK cells developing in vitro from fetal mouse progenitors express at least one member of the Ly49 family that is acquired in a time-dependent and stochastic manner independently of CD94 and NKG2. Eur J Immunol 32: 868-878.
11. Aust JG, Gays F, Hussain F, Butcher GW, Kist R, et al. (2011) Mice lacking Ly49E show normal NK cell development and provide evidence for probabilistic expression of Ly49E in NK cells and T cells. J Immunol 186: 2013-2023.
12. Smith HR, Chuang HH, Wang LL, Salcedo M, Heusel JW, et al. (2000) Nonstochastic coexpression of activation receptors on murine natural killer cells. J Exp Med 191: 1341-1354.
13. Rouhi A, Lai CB, Cheng TP, Takei F, Yokoyama WM, et al. (2009) Evidence for high bi-allelic expression of activating Ly49 receptors. Nucleic Acids Res 37: 5331-5342.
14. Toyama-Sorimachi N, Tsujimura Y, Maruya M, Onoda A, Kubota T, et al. (2004) Ly49Q, a member of the Ly49 family that is selectively expressed on myeloid lineage cells and involved in regulation of cytoskeletal architecture. Proc Natl Acad Sci U S A 101: 1016-1021.
15. Gays F, Aust JG, Reid DM, Falconer J, Toyama-Sorimachi N, et al. (2006) Ly49B is expressed on multiple subpopulations of myeloid cells. J Immunol 177: 5840-5851.
16. Kubo S, Itoh Y, Ishikawa N, Nagasawa R, Mitarai T, et al. (1993) The gene encoding mouse lymphocyte antigen Ly-49: structural analysis and the 5′-flanking sequence. Gene 136: 329-331.
17. Kunz B, Held W, (2001) Positive and negative roles of the trans-acting T cell factor-1 for the acquisition of distinct Ly-49 MHC class I receptors by NK cells. J Immunol 166: 6181-6187.
18. Wilhelm BT, McQueen KL, Freeman JD, Takei F, Mager DL, (2001) Comparative analysis of the promoter regions and transcriptional start sites of mouse Ly49 genes. Immunogenetics 53: 215-224.
19. Kubo S, Nagasawa R, Nishimura H, Shigemoto K, Maruyama N, (1999) ATF-2-binding regulatory element is responsible for the Ly49A expression in murine T lymphoid line, EL-4. Biochim Biophys Acta 1444: 191-200.
20. Gosselin P, Makrigiannis AP, Nalewaik R, Anderson SK, (2000) Characterization of the Ly49I promoter. Immunogenetics 51: 326-331.
21. McQueen KL, Wilhelm BT, Takei F, Mager DL, (2001) Functional analysis of 5′ and 3′ regions of the closely related Ly49c and j genes. Immunogenetics 52: 212-223.
22. Wasserman WW, Sandelin A, (2004) Applied bioinformatics for the identification of regulatory elements. Nat Rev Genet 5: 276-287.
23. Saleh A, Makrigiannis AP, Hodge DL, Anderson SK, (2002) Identification of a novel Ly49 promoter that is active in bone marrow and fetal thymus. J Immunol 168: 5163-5169.
24. Saleh A, Davies GE, Pascal V, Wright PW, Hodge DL, et al. (2004) Identification of probabilistic transcriptional switches in the Ly49 gene cluster: a eukaryotic mechanism for selective gene activation. Immunity 21: 55-66.
25. Maruyama K, Sugano S, (1994) Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides. Gene 138: 171-174.
26. Toomey JA, Gays F, Foster D, Brooks CG, (2003) Cytokine requirements for the growth and development of mouse NK cells in vitro. J Leukoc Biol 74: 233-242.
27. Aust JG, Gays F, Mickiewicz KM, Buchanan E, Brooks CG, (2009) The expression and function of the NKRP1 receptor family in C57BL/6 mice. J Immunol 183: 106-116.
28. Brooks CG, (2000) Cloning and culturing of fetal mouse natural killer cells. Methods Mol Biol 121: 13-24.
29. Brooks CG, Georgiou A, Jordan RK, (1993) The majority of immature fetal thymocytes can be induced to proliferate to IL-2 and differentiate into cells indistinguishable from mature natural killer cells. J Immunol 151: 6645-6656.
30. Tsutsui H, Nakanishi K, Matsui K, Higashino K, Okamura H, et al. (1996) IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J Immunol 157: 3967-3973.
31. Mazda O, Satoh E, Yasutomi K, Imanishi J, (1997) Extremely efficient gene transfection into lympho-hematopoietic cell lines by Epstein-Barr virus-based vectors. J Immunol Methods 204: 143-151.
32. Gays F, Unnikrishnan M, Shrestha S, Fraser KP, Brown AR, et al. (2000) The mouse tumor cell lines EL4 and RMA display mosaic expression of NK-related and certain other surface molecules and appear to have a common origin. J Immunol 164: 5094-5102.
33. Rouhi A, Brooks CG, Takei F, Mager DL, (2007) Plasticity of Ly49g expression is due to epigenetics. Mol Immunol 44: 821-826.
34. Powis SJ, Townsend AR, Deverson EV, Bastin J, Butcher GW, et al. (1991) Restoration of antigen presentation to the mutant cell line RMA-S by an MHC-linked transporter. Nature 354: 528-531.
35. Attaya M, Jameson S, Martinez CK, Hermel E, Aldrich C, et al. (1992) Ham-2 corrects the class I antigen-processing defect in RMA-S cells. Nature 355: 647-649.
36. Lutz MB, Granucci F, Winzler C, Marconi G, Paglia P, et al. (1994) Retroviral immortalization of phagocytic and dendritic cell clones as a tool to investigate functional heterogeneity. J Immunol Methods 174: 269-279.
37. Shen Z, Reznikoff G, Dranoff G, Rock KL, (1997) Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol 158: 2723-2730.
38. Suzuki Y, Taira H, Tsunoda T, Mizushima-Sugano J, Sese J, et al. (2001) Diverse transcriptional initiation revealed by fine, large-scale mapping of mRNA start sites. EMBO Rep 2: 388-393.
39. Shiraki T, Kondo S, Katayama S, Waki K, Kasukawa T, et al. (2003) Cap analysis gene expression for high-throughput analysis of transcriptional starting point and identification of promoter usage. Proc Natl Acad Sci U S A 100: 15776-15781.
40. Carninci P, Sandelin A, Lenhard B, Katayama S, Shimokawa K, et al. (2006) Genome-wide analysis of mammalian promoter architecture and evolution. Nat Genet 38: 626-635.
41. Kimura K, Wakamatsu A, Suzuki Y, Ota T, Nishikawa T, et al. (2006) Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes. Genome Res 16: 55-65.
42. Birney E, Stamatoyannopoulos JA, Dutta A, Guigo R, Gingeras TR, et al. (2007) Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447: 799-816.
43. Carninci P, Hayashizaki Y, (2007) Noncoding RNA transcription beyond annotated genes. Curr Opin Genet Dev 17: 139-144.
44. Frith MC, Valen E, Krogh A, Hayashizaki Y, Carninci P, et al. (2008) A code for transcription initiation in mammalian genomes. Genome Res 18: 1-12.
45. Fantom .
46. Smale ST, Kadonaga JT, (2003) The RNA polymerase II core promoter. Annu Rev Biochem 72: 449-479.
47. JASPAR-databasehttp://jaspar.cgb.ki.se/.
48. Jin VX, Singer GA, Agosto-Perez FJ, Liyanarachchi S, Davuluri RV, (2006) Genome-wide analysis of core promoter elements from conserved human and mouse orthologous pairs. BMC Bioinformatics 7: 114.
49. Tanamachi DM, Moniot DC, Cado D, Liu SD, Hsia JK, et al. (2004) Genomic Ly49A transgenes: basis of variegated Ly49A gene expression and identification of a critical regulatory element. J Immunol 172: 1074-1082.